EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Renoprotection by 5-Methoxytryptophan in Kidney Disease

Jonah P Gutierrez, Tram N Diep iD, Shaona Niu, Liang-Jun Yan iD

Biomolecules · 02.02.2026 · 16 (2) · 223

DOI: 10.3390/biom16020223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 02.02.2026. Verfasst von Jonah P Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. Hauptthemen laut MEDLINE: Tryptophan, Kidney Diseases, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of North Texas Health Science Center, Diabetes Action Research and Education Foundation, UNT Health Fort Worth.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney disease, be it acute or chronic, has a complex pathology and is a significant human health problem. Increasing interest has been focused on exploring therapeutic targets that can be used to safeguard kidney function under a variety of detrimental conditions. In this article, we review the protective effects of 5-methoxytryptophan (5-MTP), a tryptophan metabolite, on kidney injury. Published studies indicate that serum 5-MTP level is decreased in patients with chronic kidney disease (CKD), suggesting that 5-MTP is a biomarker for CKD and has therapeutic values. Indeed, rodent models of kidney injury induced by folic acid, lipopolysaccharide (LPS), unilateral ureteral obstruction (UUO), and ischemia/reperfusion all demonstrate that exogenous 5-MTP exhibits nephroprotective effects. The underlying mechanisms involve antioxidative damage via activating antioxidant systems such as heme oxygenase-1, anti-inflammation, anti-fibrosis, and enhanced mitophagy. To further explore the underlying mechanisms and the potential of 5-MTP as a kidney therapeutic compound, future studies need to include more rodent models of kidney injury induced by a variety of insults. Moreover, how to boost endogenous 5-MTP content and its potential synergistic effects with other therapeutic approaches aiming to combat kidney diseases also remain to be explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanKidney DiseasesRenal Insufficiency, ChronicHumansAnimalsKidneyAntioxidantsOxidative Stress

Stichwörter der Autor:innen

5-methoxytryptophan (5-MTP)fibrosisinflammationkidneymitophagyoxidative damage

Substanzen

Tryptophan5-methoxytryptophanAntioxidants

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

ORCID-Profile: Tram N Diep, Liang-Jun Yan

Förderung

  • University of North Texas Health Science Center
  • Diabetes Action Research and Education Foundation
  • UNT Health Fort Worth

Zitieren

APA

Gutierrez, J. P., Diep, T. N., Niu, S., & Yan, L. J. (2026). Renoprotection by 5-Methoxytryptophan in Kidney Disease. Biomolecules, 16(2), 223. https://doi.org/10.3390/biom16020223

Vancouver

Gutierrez JP, Diep TN, Niu S, Yan LJ. Renoprotection by 5-Methoxytryptophan in Kidney Disease. Biomolecules. 2026;16(2):223. doi:10.3390/biom16020223

BibTeX
@article{Gutierrez2026,
  author = {Gutierrez, Jonah P and Diep, Tram N and Niu, Shaona and Yan, Liang-Jun},
  title = {Renoprotection by 5-Methoxytryptophan in Kidney Disease},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {223},
  doi = {10.3390/biom16020223}
}
Kostenlos starten →